Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/110444
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRachidi, Fanny-
dc.contributor.authorWagner, Romy-
dc.contributor.authorFieseler, Helena-
dc.contributor.authorKaiser, Matthias-
dc.contributor.authorMüller, Hendrik-
dc.contributor.authorPodpecan, Ozbalt-
dc.contributor.authorMielenz, Norbert-
dc.contributor.authorGottschalk, Jutta-
dc.contributor.authorEinspanier, Almuth-
dc.contributor.authorMöbius, Gerd-
dc.contributor.authorBaumgartner, Walter-
dc.contributor.authorStarke, Alexander-
dc.date.accessioned2023-09-14T07:09:53Z-
dc.date.available2023-09-14T07:09:53Z-
dc.date.issued2022-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/112399-
dc.identifier.urihttp://dx.doi.org/10.25673/110444-
dc.description.abstractIntroduction: The effect of a targeted pain management protocol consisting of sedation and local anesthesia on the stress response to treatment of dermatitis interdigitalis contagiosa (DINCO) was assessed in sheep placed in dorsal recumbency. Methods: Blood cortisol concentrations were measured once a day (Day -3 to 2) and additionally on day 0, six times during the claw treatment (stress model). Twelve healthy sheep (control group; HEALTHY) and 36 sheep with DINCO, randomly allocated to one of three treatment groups, underwent the stress model with or without pain control: the XYLA-IVRA sheep were sedated with 2% xylazine hydrochloride (XYLA) and received retrograde intravenous regional anesthesia (IVRA); the IVRA sheep underwent IVRA and received a placebo instead of sedation; the PLACEBO sheep received placebos for sedation and IVRA. The HEALTHY sheep underwent sham claw treatment and received placebos. Results and discussion: The cortisol concentrations were higher in sheep restrained in dorsal recumbency compared with the cortisol concentrations measured four hours later in standing sheep (HEALTHY 37.2 ± 3.3 ng/ml vs. 18.5 ± 3.3 ng/ml; DISEASED 34.0 ± 1.9 ng/ml vs. 17.6 ± 1.9 ng/ml; p < 0.001). The stress response of XYLA-IVRA (area under the curve; AUC = 34.9 ± 2.6 ng/ml) was reduced compared with the stress response of PLACEBO (AUC = 48.0 ± 2.6 ng/ml, p < 0.01) and HEALTHY sheep (AUC = 46.6 ± 2.5 ng/ml; p = 0.01). While cortisol concentration of XYLA-IVRA and HEALTHY sheep did not increase one day after the stress model (Day 1) compared with the day of the stress model (Day 0), both PLACEBO (47.4 ± 3.3 vs. 35.6 ± 3.1 ng/ml, p = 0.02) and IVRA sheep (39.1 ± 2.8 vs. 28.6 ± 3.1 ng/ml, p = 0.01) had higher cortisol concentrations. The results confirm that fixation in dorsal recumbency in a tilt squeeze chute was a major stressor in sheep. The differences in the cortisol concentration of the PLACEBO sheep versus the XYLA-IVRA sheep during and after the stress model illustrate the effect and necessity of pain management protocols in practice.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc599-
dc.titleEffect of a targeted pain management protocol for the treatment of dermatitis interdigitalis contagiosa in Merino meat sheep in a tilt squeeze chuteeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleFrontiers in animal science-
local.bibliographicCitation.volume3-
local.bibliographicCitation.pagestart1-
local.bibliographicCitation.pageend16-
local.bibliographicCitation.publishernameFrontiers Media-
local.bibliographicCitation.publisherplaceLausanne-
local.bibliographicCitation.doi10.3389/fanim.2022.1021039-
local.subject.keywordscortisol, stress, dorsal recumbency, tilt squeeze chute, claw treatment, regional anesthesia, sedation, pain mitigation-
local.openaccesstrue-
dc.identifier.ppn1859501885-
cbs.publication.displayform2022-
local.bibliographicCitation.year2022-
cbs.sru.importDate2023-09-14T07:09:14Z-
local.bibliographicCitationEnthalten in Frontiers in animal science - Lausanne : Frontiers Media, 2020-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
fanim-03-1021039.pdf880.04 kBAdobe PDFThumbnail
View/Open